
Researchers begin to map epigenetic methylation in specific cancer drug resistance.
A team of researchers led by Duke Cancer Institute have identified key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies. By mapping the points of … Continue Reading Researchers begin to map epigenetic methylation in specific cancer drug resistance.